Nubia Munoz

Summary

Country: France

Publications

  1. pmc Predictors of human papillomavirus infection in women undergoing routine cervical cancer screening in Spain: the CLEOPATRE study
    Esther Roura
    Cancer Epidemiology Research Program, Institut Català d Oncologia IDIBELL, CIBER ESP, RTICC, L Hospitalet de Llobregat, Barcelona, Catalonia, Spain
    BMC Infect Dis 12:145. 2012
  2. doi Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24-45 years: a randomised, double-blind trial
    Nubia Munoz
    National Institute of Cancer, Bogota, Colombia
    Lancet 373:1949-57. 2009
  3. doi Recommendations for cervical cancer prevention in Latin America and the Caribbean
    Nubia Munoz
    Instituto Nacional de Cancerologia, Bogota, Colombia
    Vaccine 26:L96-L107. 2008
  4. doi [What should be known for the introduction of an HPV vaccine?]
    Nubia Munoz
    Instituto Nacional de Cancerologia, Bogota, Colombia
    Presse Med 37:1377-90. 2008
  5. doi Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women
    Nubia Munoz
    Division of Research and Public Health, National Institute of Cancer, Bogota, Colombia
    J Natl Cancer Inst 102:325-39. 2010
  6. ncbi Chapter 1: HPV in the etiology of human cancer
    Nubia Munoz
    Institut Català d Oncologia ICO, 24 Quai Fulchiron, Lyon, France
    Vaccine 24:S3/1-10. 2006
  7. doi From causality to prevention - the example of cervical cancer: my personal contribution to this fascinating history
    Nubia Munoz
    IARC, Lyon, France
    Public Health Genomics 12:368-71. 2009
  8. ncbi Chlamydia trachomatis and invasive cervical cancer: a pooled analysis of the IARC multicentric case-control study
    Jennifer S Smith
    International Agency for Research on Cancer, Lyon, France
    Int J Cancer 111:431-9. 2004
  9. doi Smoking and human papillomavirus infection: pooled analysis of the International Agency for Research on Cancer HPV Prevalence Surveys
    Salvatore Vaccarella
    International Agency for Research on Cancer, Lyon, France
    Int J Epidemiol 37:536-46. 2008
  10. ncbi Variations in the age-specific curves of human papillomavirus prevalence in women worldwide
    Silvia Franceschi
    International Agency for Research on Cancer, Lyon, France
    Int J Cancer 119:2677-84. 2006

Detail Information

Publications19

  1. pmc Predictors of human papillomavirus infection in women undergoing routine cervical cancer screening in Spain: the CLEOPATRE study
    Esther Roura
    Cancer Epidemiology Research Program, Institut Català d Oncologia IDIBELL, CIBER ESP, RTICC, L Hospitalet de Llobregat, Barcelona, Catalonia, Spain
    BMC Infect Dis 12:145. 2012
    ..The aim of the current study was to investigate socio-demographic, lifestyle, and medical factors for potential associations with cervical HPV infection in women undergoing cervical cancer screening in Spain...
  2. doi Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24-45 years: a randomised, double-blind trial
    Nubia Munoz
    National Institute of Cancer, Bogota, Colombia
    Lancet 373:1949-57. 2009
    ..We tested the safety, immunogenicity, and efficacy of the quadrivalent HPV (types 6, 11, 16, 18) L1 virus-like-particle vaccine in women aged 24-45 years...
  3. doi Recommendations for cervical cancer prevention in Latin America and the Caribbean
    Nubia Munoz
    Instituto Nacional de Cancerologia, Bogota, Colombia
    Vaccine 26:L96-L107. 2008
    ....
  4. doi [What should be known for the introduction of an HPV vaccine?]
    Nubia Munoz
    Instituto Nacional de Cancerologia, Bogota, Colombia
    Presse Med 37:1377-90. 2008
    ....
  5. doi Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women
    Nubia Munoz
    Division of Research and Public Health, National Institute of Cancer, Bogota, Colombia
    J Natl Cancer Inst 102:325-39. 2010
    ....
  6. ncbi Chapter 1: HPV in the etiology of human cancer
    Nubia Munoz
    Institut Català d Oncologia ICO, 24 Quai Fulchiron, Lyon, France
    Vaccine 24:S3/1-10. 2006
    ..Genetic and immunological host factors and viral factors other than type, such as variants of type, viral load and viral integration, are likely to be important but have not been clearly identified...
  7. doi From causality to prevention - the example of cervical cancer: my personal contribution to this fascinating history
    Nubia Munoz
    IARC, Lyon, France
    Public Health Genomics 12:368-71. 2009
    ..The history of the generation of an hypothesis linking human papillomavirus to cervical cancer, as well as a summary of the various molecular epidemiological studies undertaken to confirm such hypothesis are described...
  8. ncbi Chlamydia trachomatis and invasive cervical cancer: a pooled analysis of the IARC multicentric case-control study
    Jennifer S Smith
    International Agency for Research on Cancer, Lyon, France
    Int J Cancer 111:431-9. 2004
    ..0; 95% CI = 0.53-1.9) in HPV DNA-positive women. An association of C. trachomatis with squamous cell ICC was found among all cases and control women with or without adjustment for HPV...
  9. doi Smoking and human papillomavirus infection: pooled analysis of the International Agency for Research on Cancer HPV Prevalence Surveys
    Salvatore Vaccarella
    International Agency for Research on Cancer, Lyon, France
    Int J Epidemiol 37:536-46. 2008
    ..Smoking increases the risk of squamous-cell carcinoma of the cervix, but it is not clear whether smoking increases the risk of acquisition or persistence of human papillomavirus (HPV) infection...
  10. ncbi Variations in the age-specific curves of human papillomavirus prevalence in women worldwide
    Silvia Franceschi
    International Agency for Research on Cancer, Lyon, France
    Int J Cancer 119:2677-84. 2006
    ..These differences, however, underline that great caution should be used in inferring the natural history of HPV from age-specific prevalences...
  11. ncbi Human papillomavirus and risk factors for cervical cancer in Chennai, India: a case-control study
    Silvia Franceschi
    International Agency for Research on Cancer, Lyon, France
    Int J Cancer 107:127-33. 2003
    ..A vaccine against HPV 16 and 18 may be effective in more than three-quarters of ICC in the study area...
  12. ncbi Herpes simplex virus-2 as a human papillomavirus cofactor in the etiology of invasive cervical cancer
    Jennifer S Smith
    Unit of Field and Intervention Studies, International Agency for Research on Cancer IARC, Lyon, France
    J Natl Cancer Inst 94:1604-13. 2002
    ..We performed a pooled analysis of seven case-control studies to examine the effect of one possible HPV cofactor, herpes simplex virus-2 (HSV-2) infection, in the etiology of invasive cervical cancer...
  13. ncbi Against which human papillomavirus types shall we vaccinate and screen? The international perspective
    Nubia Munoz
    International Agency for Research on Cancer, Lyon, France
    Int J Cancer 111:278-85. 2004
    ..The impact of modifying the number of types in the screening cocktail tests would be small and probably irrelevant for screening programs...
  14. ncbi Role of parity and human papillomavirus in cervical cancer: the IARC multicentric case-control study
    Nubia Munoz
    Unit of Field and Intervention Studies, International Agency for Research on Cancer, 150 cours Albert Thomas, F 69372, Cedex 08, Lyon, France
    Lancet 359:1093-101. 2002
    ..To assess the role of reproductive factors in the progression from HPV infection to cancer, we did a pooled analysis including only HPV-positive women...
  15. ncbi Short-term risk of cervical intraepithelial neoplasia grades 2 and 3 for women with normal cytology and human papillomavirus infection
    Gustavo Hernández-Suárez
    Instituto Nacional de Cancerologia, Bogota, Colombia
    Salud Publica Mex 52:486-92. 2010
    ..To assess the risk of cervical intraepithelial neoplasia grades 2, 3 or higher (CIN 2/3+) for women with normal cytology and concurrent high-risk human papillomavirus infection (HR-HPV)...
  16. ncbi Cervical infection with Chlamydia trachomatis and Neisseria gonorrhoeae in women from ten areas in four continents. A cross-sectional study
    Silvia Franceschi
    International Agency for Research on Cancer, Lyon, France
    Sex Transm Dis 34:563-9. 2007
    ..Better information on the prevalence of Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) infection is needed in many world areas...
  17. ncbi Incidence, duration, and determinants of cervical human papillomavirus infection in a cohort of Colombian women with normal cytological results
    Nubia Munoz
    Instituto Nacional de Cancerologia, Bogota, Colombia
    J Infect Dis 190:2077-87. 2004
    ..8 vs. 11.1 months). In this cohort of cytologically normal women, the incidence of cervical HPV infection was high, and the epidemiological profile of high-risk HPV types was different from that of low-risk types...
  18. ncbi Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) L1 virus-like-particle vaccine in Latin American women
    Gonzalo Perez
    National Research Center, Group Saludcoop, Bogota, Colombia
    Int J Cancer 122:1311-8. 2008
    ..These data support vaccination of adolescents and young adults in the region, which is expected to greatly reduce the burden of cervical and genital cancers, precancers and genital warts...
  19. pmc Maté drinking and esophageal squamous cell carcinoma in South America: pooled results from two large multicenter case-control studies
    Jay H Lubin
    Authors Affiliations Biostatistics Branch and Nutritional Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, Maryland Epidemiology Group, Department of Pathology Department of Pathology, School of Medicine, University of the Republic Deneo Pellegrini, Director, Department of Pathology, Cancer Institute Unit of Oncology and Radiotherapy, Pereira Rossell Women s Hospital, Montevideo IUCLAEH School of Medicine, Maldonado, Uruguay The Tisch Cancer Institute, Mount Sinai School of Medicine, New York, New York Post Graduate Program in Epidemiology, Federal University of Pelotas, Pelotas, Rio Grande do Sul, Brazil Nubia Muñoz, Cancer Institute of Colombia, Bogota, Colombia Infections and Cancer Epidemiology Group, International Agency for Research on Cancer, Lyon, France and Catalan Institute of Oncology ICO, IDIBELL, CIBERESP, L Hospitalet de Llobregat 08908, Catalonia, Spain
    Cancer Epidemiol Biomarkers Prev 23:107-16. 2014
    ..Maté tea is a nonalcoholic infusion widely consumed in southern South America, and may increase risk of esophageal squamous cell carcinoma (ESCC) and other cancers due to polycyclic aromatic hydrocarbons (PAH) and/or thermal injury...